Episodio – Inhibidores SGLT-2 (canagliflozina, dapagliflozina) y su efecto en la presión arterial | USMLE Step 1 episode artwork

EPISODE · Dec 9, 2025 · 4 MIN

Episodio – Inhibidores SGLT-2 (canagliflozina, dapagliflozina) y su efecto en la presión arterial | USMLE Step 1

from USMLE DREAMERS · host USMLE DREAMERS

Canagliflozina y dapagliflozina, inhibidores SGLT-2, reducen glucosa, presión arterial y riesgo cardiovascular. En este episodio repasamos su mecanismo, beneficios y por qué disminuyen la presión arterial.#USMLE #Step1 #SGLT2 #Canagliflozina #Dapagliflozina #Farmacología

Episode metadata supplied by the publisher feed · Published Dec 9, 2025

Embed this episode

Ready to play

Episodio – Inhibidores SGLT-2 (canagliflozina, dapagliflozina) y su efecto en la presión arterial | USMLE Step 1

0:00 4:09

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of USMLE DREAMERS?

This episode is 4 minutes long.

When was this USMLE DREAMERS episode published?

This episode was published on December 9, 2025.

Can I download this USMLE DREAMERS episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!